Skip to main content
Clinical Trials/ACTRN12608000471381
ACTRN12608000471381
Not yet recruiting
Phase 4

A randomised, double blinded, controlled trial of standard analgesia + Gabapentin versus standard analgesia + placebo for post thoracotomy analgesia to determine the impact of gabapentin on post thoracotomy pain at 3 months.

Dr John Monagle0 sites102 target enrollmentSeptember 22, 2008

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Prevention of a chronic pain syndrome developing post thoracotomy.
Sponsor
Dr John Monagle
Enrollment
102
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr John Monagle

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing open thoracic surgery who are 18 years old or older and have an anticipated post operative stay of greater than twenty four hours.

Exclusion Criteria

  • Patients who have a known hyper sensitvity to Gabapentin. Women who are pregnant or breast feeding. Patients who are currently using Gabapentin. Patients who have chronic renal insufficiency (pre\-operative creatinine level\> 200 umol/L or are receiving dialysis. Patients with a history of chronic pain syndrome. patients currently using Cimetidine or regular antacids or have a history of epilepsy or seizures. Patients with a history of alcoholism or recreational drug use.

Outcomes

Primary Outcomes

Not specified

Similar Trials